Fosun International LTD Immuno Gen, Inc. Transaction History

Fosun International LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$2.41 - $5.91 $599,485 - $1.47 Million	-248,749 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$3.94 - $9.7 $275,800 - $679,000	70,000 Added 39.16%	248,749 $1.11 Million
Q3 2018 Nov 09, 2018	BUY	$8.6 - $11.26 $1.54 Million - $2.01 Million	178,749 New	178,749 $1.72 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.